Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Gold

Showing results (251-260 of 321) with videos related to

Pageof 33
Sort By:
Clinical Endocrinology|October 1, 1995
Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic featuresL D Dorn, E S Burgess, B Dubbert, et al.
Brain Research|November 26, 1993
Facilitation of cocaine kindling by glucocorticoids in ratsM A Kling, M A Smith, J R Glowa, et al.
Endocrinology|July 1, 1985
Effects and pharmacokinetic properties of the rat/human corticotropin-releasing factor in rhesus monkeysT H Schürmeyer, P W Gold, W T Gallucci, et al.
The Journal of Clinical Investigation|June 1, 1985
Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implicationsH M Schulte, G P Chrousos, P W Gold, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1983
Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulationP W Gold, G L Robertson, J C Ballenger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Abnormal ACTH and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorderP W Gold, J R Calabrese, M A Kling, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1992
Effects of carbamazepine on pituitary-adrenal function in healthy volunteersG I Perini, O Devinsky, P Hauser, et al.
Translational Psychiatry|June 3, 2015
Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implicationsP W Gold, M G Pavlatou, D Michelson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implicationsK T Kalogeras, A E Calogero, T Kuribayiashi, et al.
Neuroimmunomodulation|January 1, 1994
Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer ratsC C Smith, R J Omeljaniuk, H J Whitfield, et al.
Pageof 33

Showing results (251-260 of 321) with videos related to

Sort By:
Pageof 33
Clinical Endocrinology|October 1, 1995
Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic featuresL D Dorn, E S Burgess, B Dubbert, et al.
Brain Research|November 26, 1993
Facilitation of cocaine kindling by glucocorticoids in ratsM A Kling, M A Smith, J R Glowa, et al.
Endocrinology|July 1, 1985
Effects and pharmacokinetic properties of the rat/human corticotropin-releasing factor in rhesus monkeysT H Schürmeyer, P W Gold, W T Gallucci, et al.
The Journal of Clinical Investigation|June 1, 1985
Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implicationsH M Schulte, G P Chrousos, P W Gold, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1983
Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulationP W Gold, G L Robertson, J C Ballenger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Abnormal ACTH and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorderP W Gold, J R Calabrese, M A Kling, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1992
Effects of carbamazepine on pituitary-adrenal function in healthy volunteersG I Perini, O Devinsky, P Hauser, et al.
Translational Psychiatry|June 3, 2015
Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implicationsP W Gold, M G Pavlatou, D Michelson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implicationsK T Kalogeras, A E Calogero, T Kuribayiashi, et al.
Neuroimmunomodulation|January 1, 1994
Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer ratsC C Smith, R J Omeljaniuk, H J Whitfield, et al.
Pageof 33